These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38229878)

  • 1. Long-term predictors of developmental outcome and disease burden in
    Feng T; Makiello P; Dunwoody B; Steckler F; Symonds JD; Zuberi SM; Dorris L; Brunklaus A
    Brain Commun; 2024; 6(1):fcae004. PubMed ID: 38229878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities and predictors of health-related quality of life in Dravet syndrome: A 10-year, prospective follow-up study.
    Makiello P; Feng T; Dunwoody B; Steckler F; Symonds J; Zuberi SM; Dorris L; Brunklaus A
    Epilepsia; 2023 Apr; 64(4):1012-1020. PubMed ID: 36740581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
    Lopez-Santiago L; Isom LL
    Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Dravet Syndrome: Characterization of a Novel, More Severe SCN1A-Linked Epileptic Encephalopathy.
    Beck VC; Hull JM; Isom LL
    Epilepsy Curr; 2019; 19(4):266-268. PubMed ID: 31257984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities and predictors of health-related quality of life in Dravet syndrome.
    Brunklaus A; Dorris L; Zuberi SM
    Epilepsia; 2011 Aug; 52(8):1476-82. PubMed ID: 21668444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Prediction Model for Early Diagnosis of
    Brunklaus A; Pérez-Palma E; Ghanty I; Xinge J; Brilstra E; Ceulemans B; Chemaly N; de Lange I; Depienne C; Guerrini R; Mei D; Møller RS; Nabbout R; Regan BM; Schneider AL; Scheffer IE; Schoonjans AS; Symonds JD; Weckhuysen S; Kattan MW; Zuberi SM; Lal D
    Neurology; 2022 Mar; 98(11):e1163-e1174. PubMed ID: 35074891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.
    Brunklaus A; Ellis R; Reavey E; Forbes GH; Zuberi SM
    Brain; 2012 Aug; 135(Pt 8):2329-36. PubMed ID: 22719002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
    Li W; Schneider AL; Scheffer IE
    Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome.
    Lersch R; Jannadi R; Grosse L; Wagner M; Schneider MF; von Stülpnagel C; Heinen F; Potschka H; Borggraefe I
    Neuroscientist; 2023 Dec; 29(6):732-750. PubMed ID: 35414300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A+ Dravet syndrome: Insights from the ENVISION natural history study.
    Perry MS; Scheffer IE; Sullivan J; Brunklaus A; Boronat S; Wheless JW; Laux L; Patel AD; Roberts CM; Dlugos D; Holder D; Knupp KG; Lallas M; Phillips S; Segal E; Smeyers P; Lal D; Wirrell E; Zuberi S; Brünger T; Wojnaroski M; Maru B; O'Donnell P; Morton M; James E; Vila MC; Huang N; Gofshteyn JS; Rico S
    Epilepsia; 2024 Feb; 65(2):322-337. PubMed ID: 38049202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCN1A-deficient excitatory neuronal networks display mutation-specific phenotypes.
    van Hugte EJH; Lewerissa EI; Wu KM; Scheefhals N; Parodi G; van Voorst TW; Puvogel S; Kogo N; Keller JM; Frega M; Schubert D; Schelhaas HJ; Verhoeven J; Majoie M; van Bokhoven H; Nadif Kasri N
    Brain; 2023 Dec; 146(12):5153-5167. PubMed ID: 37467479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all
    Sadleir LG; Mountier EI; Gill D; Davis S; Joshi C; DeVile C; Kurian MA; ; Mandelstam S; Wirrell E; Nickels KC; Murali HR; Carvill G; Myers CT; Mefford HC; Scheffer IE
    Neurology; 2017 Sep; 89(10):1035-1042. PubMed ID: 28794249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
    Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
    Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology.
    Catarino CB; Liu JY; Liagkouras I; Gibbons VS; Labrum RW; Ellis R; Woodward C; Davis MB; Smith SJ; Cross JH; Appleton RE; Yendle SC; McMahon JM; Bellows ST; Jacques TS; Zuberi SM; Koepp MJ; Martinian L; Scheffer IE; Thom M; Sisodiya SM
    Brain; 2011 Oct; 134(Pt 10):2982-3010. PubMed ID: 21719429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.
    Kwong AK; Fung CW; Chan SY; Wong VC
    PLoS One; 2012; 7(7):e41802. PubMed ID: 22848613
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.